AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 1421050 — intervention group
Group type: COMPARATOR
Intervention: carbamazepine OROS controlled delivery tablets
Number of subjects: 34
Study 3882676 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 0
Study 3882676 — intervention group
Group type: COMPARATOR
Intervention: Doxepin
Number of subjects: 0
Study 31557810 — intervention group
Group type: EXPERIMENTAL
Intervention: Facility List Coder (FLC)
Number of subjects: 301
Study 29704217 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking as usual (n=50)
Number of subjects: 128
Study 29704217 — intervention group
Group type: COMPARATOR
Intervention: Overnight abstinence (n=50 successfully abstained, n=22 failed abstaining)
Number of subjects: 128
Study 29704217 — intervention group
Group type: EXPERIMENTAL
Intervention: Not applicable
Number of subjects: 128
Study 27510380 — intervention group
Group type: EXPERIMENTAL
Intervention: DTaP‐IPV//Hib pentavalent combination vaccine (Pentaxim™)
Number of subjects: 418
Study 27510380 — intervention group
Group type: COMPARATOR
Intervention: Separate DTaP‐IPV and Hib vaccines
Number of subjects: 418
Study 25061038 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-wave diathermy (SWD) treatment
Number of subjects: 31
Study 25061038 — intervention group
Group type: COMPARATOR
Intervention: Placebo SWD treatment
Number of subjects: 31
Study 24114748 — intervention group
Group type: EXPERIMENTAL
Intervention: Free rehabilitation (n = 32): 2 weeks of ROM 0°-90°, no brace, touch weightbearing, unrestricted activity and free ROM thereafter.
Number of subjects: 60
Study 24114748 — intervention group
Group type: COMPARATOR
Intervention: Restricted rehabilitation (n = 28): 6 weeks of hinged brace use, gradual increase of ROM to 90°, only touch weightbearing during the 6 weeks.
Number of subjects: 60
Study 24114748 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with repair failure who underwent subsequent partial meniscectomy.
Number of subjects: 60
Study 24114748 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall outcomes for both groups (free and restricted rehabilitation).
Number of subjects: 60
Study 22121446 — intervention group
Group type: EXPERIMENTAL
Intervention: Health education intervention in Kake II (experimental arm)
Number of subjects: 370
Study 22121446 — intervention group
Group type: COMPARATOR
Intervention: Control group in Barombi-Kang
Number of subjects: 370
Study 19451282 — intervention group
Group type: EXPERIMENTAL
Intervention: EDP-420 (400 mg/day loading dose, followed by 200 mg/day for 2 days)
Number of subjects: 0
Study 19451282 — intervention group
Group type: COMPARATOR
Intervention: EDP-420 capsule formulation
Number of subjects: 0
Study 19451282 — intervention group
Group type: COMPARATOR
Intervention: EDP-420 suspension formulation
Number of subjects: 0
Study 16505262 — intervention group
Group type: EXPERIMENTAL
Intervention: Cholecalciferol (700 IU) plus Calcium Citrate Malate (500 mg)
Number of subjects: 445
Study 16505262 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 445
Study 14630381 — intervention group
Group type: EXPERIMENTAL
Intervention: Discussing patient's ideas about their disorder
Number of subjects: 108
Study 14630381 — intervention group
Group type: EXPERIMENTAL
Intervention: Discussing patient's action plans
Number of subjects: 108
Study 14630381 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual consultation
Number of subjects: 108
Study 10676679 — intervention group
Group type: EXPERIMENTAL
Intervention: PC180 (180 s ischemia)
Number of subjects: 46
Study 10676679 — intervention group
Group type: EXPERIMENTAL
Intervention: NC (80 microg/kg)
Number of subjects: 46
Study 10676679 — intervention group
Group type: COMPARATOR
Intervention: PC60 (60 s ischemia)
Number of subjects: 46
Study 10676679 — intervention group
Group type: COMPARATOR
Intervention: ISDN (40 microg/kg)
Number of subjects: 46
Study 9039852 — intervention group
Group type: EXPERIMENTAL
Intervention: Dairy-containing diet
Number of subjects: 25
Study 9039852 — intervention group
Group type: EXPERIMENTAL
Intervention: Nondairy-containing diet
Number of subjects: 25
Study 9039852 — intervention group
Group type: COMPARATOR
Intervention: Baseline diet
Number of subjects: 25
Study 9039852 — intervention group
Group type: EXPERIMENTAL
Intervention: Second days in laboratory
Number of subjects: 25
Study 8000747 — intervention group
Group type: EXPERIMENTAL
Intervention: Verum acupuncture treatment at non-segmental distal points (homolateral leg)
Number of subjects: 48
Study 8000747 — intervention group
Group type: COMPARATOR
Intervention: Placebo acupuncture (avoiding penetration of the skin)
Number of subjects: 48
Study 3287976 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotetan 2 g once daily
Number of subjects: 194
Study 3287976 — intervention group
Group type: COMPARATOR
Intervention: Cefoxitin 1 or 2 g three times daily
Number of subjects: 194
Study 3287976 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotetan
Number of subjects: 194
Study 3287976 — intervention group
Group type: COMPARATOR
Intervention: Cefoxitin
Number of subjects: 194
Study 30030775 — intervention group
Group type: EXPERIMENTAL
Intervention: Low Intensity Aerobic Exercise with Blood Flow Restriction (LIAE + BFR)
Number of subjects: 16
Study 30030775 — intervention group
Group type: COMPARATOR
Intervention: High Intensity Aerobic Exercise (HIAE)
Number of subjects: 16
Study 30030775 — intervention group
Group type: COMPARATOR
Intervention: Low Intensity Aerobic Exercise (LIAE)
Number of subjects: 16
Study 28028866 — intervention group
Group type: EXPERIMENTAL
Intervention: Workplace physical exercise (WORK) performed in groups during working hours for 5 × 10 minutes per week and up to five group‐based coaching sessions on motivation for regular physical exercise
Number of subjects: 200
Study 28028866 — intervention group
Group type: COMPARATOR
Intervention: Home‐based physical exercise (HOME) performed alone during leisure‐time for 5 × 10 minutes per week
Number of subjects: 200
Study 26233970 — intervention group
Group type: EXPERIMENTAL
Intervention: Marginal Periosteal Membrane (MPM)
Number of subjects: 30
Study 26233970 — intervention group
Group type: EXPERIMENTAL
Intervention: Marginal Periosteal Membrane (MPM) with Demineralized Freeze-Dried Bone Allograft (DFDBA)
Number of subjects: 30
Study 26233970 — intervention group
Group type: COMPARATOR
Intervention: Open Flap Debridement (OFD)
Number of subjects: 30
Study 24453079 — intervention group
Group type: EXPERIMENTAL
Intervention: Bezafibrate 200 mg 3 times daily
Number of subjects: 10
Study 24453079 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 10
Study 22915294 — intervention group
Group type: EXPERIMENTAL
Intervention: Cowpea meal fortified with 10 mg Fe/meal as NaFeEDTA
Number of subjects: 241
Study 22915294 — intervention group
Group type: COMPARATOR
Intervention: Nonfortified cowpea meal
Number of subjects: 241
Study 20420745 — intervention group
Group type: EXPERIMENTAL
Intervention: Dilated cardiomyopathy patients
Number of subjects: 23
Study 19115654 — intervention group
Group type: COMPARATOR
Intervention: Lignocaine alone (9 ml of 2% lignocaine diluted with normal saline to total volume of 36 ml)
Number of subjects: 30
Study 19115654 — intervention group
Group type: EXPERIMENTAL
Intervention: Lignocaine plus magnesium sulphate (6 ml of 25% magnesium sulphate plus 9 ml of 2% lignocaine diluted with normal saline to total volume of 36 ml)
Number of subjects: 30
Study 19115654 — intervention group
Group type: EXPERIMENTAL
Intervention: Lignocaine plus magnesium sulphate
Number of subjects: 30
Study 19115654 — intervention group
Group type: COMPARATOR
Intervention: Lignocaine alone
Number of subjects: 30
Study 16235974 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat plus diet
Number of subjects: 0
Study 16235974 — intervention group
Group type: COMPARATOR
Intervention: Diet only
Number of subjects: 0
Study 12084443 — intervention group
Group type: EXPERIMENTAL
Intervention: Peripheral silent period in ET patients
Number of subjects: 24
Study 12084443 — intervention group
Group type: COMPARATOR
Intervention: Peripheral silent period in healthy controls
Number of subjects: 24
Study 11482123 — intervention group
Group type: EXPERIMENTAL
Intervention: Preventive services benefit package
Number of subjects: 0
Study 11482123 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study 9169299 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 405
Study 9169299 — intervention group
Group type: COMPARATOR
Intervention: Amitriptyline
Number of subjects: 405
Study 8330606 — intervention group
Group type: EXPERIMENTAL
Intervention: Forearm elevation to 0 cm above heart
Number of subjects: 20
Study 8330606 — intervention group
Group type: EXPERIMENTAL
Intervention: Forearm elevation to 18 cm above heart
Number of subjects: 20
Study 8330606 — intervention group
Group type: EXPERIMENTAL
Intervention: Forearm elevation to 36 cm above heart
Number of subjects: 20
Study 8330606 — intervention group
Group type: EXPERIMENTAL
Intervention: Forearm blood flow at heart level
Number of subjects: 20
Study 8330606 — intervention group
Group type: EXPERIMENTAL
Intervention: Total vascular resistance at heart level
Number of subjects: 20
Study 3943744 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyoscine‐N‐butylbromide (20 mg IV)
Number of subjects: 12
Study 3943744 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyoscine‐N‐butylbromide (40 mg IV)
Number of subjects: 12
Study 3943744 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 12
Study 31393811 — intervention group
Group type: EXPERIMENTAL
Intervention: Mastery Motivational Climate (MMC) intervention
Number of subjects: 96
Study 31393811 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (no specific intervention mentioned)
Number of subjects: 96
Study 30188253 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsed Nd:YAG laser combined with an exercise program
Number of subjects: 60
Study 30188253 — intervention group
Group type: COMPARATOR
Intervention: Sham laser combined with an exercise program
Number of subjects: 60
Study 27671996 — intervention group
Group type: EXPERIMENTAL
Intervention: Swiss ball
Number of subjects: 36
Study 27671996 — intervention group
Group type: EXPERIMENTAL
Intervention: Dumbbells
Number of subjects: 36
Study 27671996 — intervention group
Group type: COMPARATOR
Intervention: Smith machine
Number of subjects: 36
Study 24767296 — intervention group
Group type: EXPERIMENTAL
Intervention: Short-term thromboprophylaxis with oral rivaroxaban 10 mg once daily for 7 days
Number of subjects: 40
Study 24767296 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term thromboprophylaxis with oral rivaroxaban 10 mg once daily for 35 days
Number of subjects: 40
Study 24767296 — intervention group
Group type: COMPARATOR
Intervention: Control group (short-term thromboprophylaxis)
Number of subjects: 40
Study 24767296 — intervention group
Group type: COMPARATOR
Intervention: Control group (long-term thromboprophylaxis)
Number of subjects: 40
Study 23248894 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel multi-directional power toothbrush (Oral-B Professional Deep Sweep TRICLEAN 1000)
Number of subjects: 119
Study 23248894 — intervention group
Group type: COMPARATOR
Intervention: Standard soft manual control toothbrush
Number of subjects: 119
Study 20975473 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural analgesia
Number of subjects: 321
Study 19192854 — intervention group
Group type: EXPERIMENTAL
Intervention: Abstinence-contingent monetary payments for 14 days with 0, 1, or 8 experimenter-delivered cigarette puffs
Number of subjects: 58
Study 19192854 — intervention group
Group type: COMPARATOR
Intervention: Abstinence-contingent monetary payments for 1 day
Number of subjects: 58
Study 16014402 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein/low-fat diet (34% protein/29% fat)
Number of subjects: 57
Study 16014402 — intervention group
Group type: COMPARATOR
Intervention: Standard protein/high-fat diet (18% protein/45% fat)
Number of subjects: 57
Study 16014402 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein/low-fat diet
Number of subjects: 57
Study 11978683 — intervention group
Group type: EXPERIMENTAL
Intervention: NVP DPP728 at 100 mg t.i.d.
Number of subjects: 93
Study 11978683 — intervention group
Group type: EXPERIMENTAL
Intervention: NVP DPP728 at 150 mg b.i.d.
Number of subjects: 93
Study 11978683 — intervention group
Group type: EXPERIMENTAL
Intervention: NVP DPP728 (combined active treatment groups)
Number of subjects: 93
Study 11978683 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study 11978683 — intervention group
Group type: EXPERIMENTAL
Intervention: NVP DPP728 at 100 mg t.i.d. and 150 mg b.i.d.
Number of subjects: 93
Study 10599480 — intervention group
Group type: EXPERIMENTAL
Intervention: Children at high risk for anxiety disorders
Number of subjects: 192
Study 10599480 — intervention group
Group type: COMPARATOR
Intervention: Other children
Number of subjects: 192
Study 7568603 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured statement of exercise intention after three 90-min educational sessions
Number of subjects: 111
Study 7568603 — intervention group
Group type: COMPARATOR
Intervention: Control group (no structured statement of intention)
Number of subjects: 111
Study 7568603 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured statements of intention
Number of subjects: 111
Study 8095941 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergic subjects after allergen challenge (Parietaria judaica)
Number of subjects: 30
Study 8095941 — intervention group
Group type: COMPARATOR
Intervention: Healthy individuals after allergen challenge (Parietaria judaica)
Number of subjects: 30
Study 2871819 — intervention group
Group type: EXPERIMENTAL
Intervention: Diazepam (4.4 to 140 micrograms/kg, cumulative dose)
Number of subjects: 10
Study 2871819 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 30043330 — intervention group
Group type: EXPERIMENTAL
Intervention: G‐CSF + plerixafor (GP arm)
Number of subjects: 32
Study 30043330 — intervention group
Group type: COMPARATOR
Intervention: G‐CSF alone (G arm)
Number of subjects: 32
Study 27764050 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (1000 mg daily)
Number of subjects: 22
Study 27764050 — intervention group
Group type: EXPERIMENTAL
Intervention: Topiramate (100 mg daily)
Number of subjects: 22
Study 27764050 — intervention group
Group type: COMPARATOR
Intervention: Control group (10 obese patients with schizophrenia)
Number of subjects: 22
Study 24632673 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human activated protein C (rh-APC) 24 mcg/kg/h for 4 days
Number of subjects: 71
Study 24632673 — intervention group
Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 71
Study 24632673 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human activated protein C (rh-APC)
Number of subjects: 71
Study 22572649 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin (200 mg in 20 mL 0.9% saline)
Number of subjects: 32
Study 22572649 — intervention group
Group type: COMPARATOR
Intervention: Placebo (20 mL 0.9% saline)
Number of subjects: 32
Study 20090428 — intervention group
Group type: COMPARATOR
Intervention: Placebo or sham-controlled intervention
Number of subjects: 0
Study 18612039 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent cell phone interviews (Parent-Child Activities Interview)
Number of subjects: 589
Study 18612039 — intervention group
Group type: COMPARATOR
Intervention: Less frequent interviews over home telephone
Number of subjects: 589
Study 18612039 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-Child Activities Interview
Number of subjects: 589
Study 16006230 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver correlates including demographics, behaviors, family environment, perceptions of parent/adolescent interaction, coping strategies, caregiver monitoring of youth, and self-reported substance use.
Number of subjects: 218
Study 12089229 — intervention group
Group type: EXPERIMENTAL
Intervention: ChlVPP/EVA hybrid
Number of subjects: 282
Study 12089229 — intervention group
Group type: COMPARATOR
Intervention: VAPEC-B
Number of subjects: 282
Study 10557684 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive group education and peer review programme (four sessions each lasting two hours)
Number of subjects: 433
Study 10557684 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 433
Study 8540714 — intervention group
Group type: EXPERIMENTAL
Intervention: Ceftazidime 25 mg/kg once daily
Number of subjects: 28
Study 8540714 — intervention group
Group type: COMPARATOR
Intervention: Ceftazidime 25 mg/kg twice daily
Number of subjects: 28
Study 1786500 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramiracetam sulphate 400 mg TID
Number of subjects: 0
Study 1786500 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 6821435 — intervention group
Group type: EXPERIMENTAL
Intervention: Staged, intact canal wall tympanoplasties
Number of subjects: 0
Study 6821435 — intervention group
Group type: COMPARATOR
Intervention: Staged, modified radical mastoidectomies with cavity obliteration and tympanoplasty
Number of subjects: 0
Study 31343513 — intervention group
Group type: EXPERIMENTAL
Intervention: MiSight 1-day contact lens (test)
Number of subjects: 144
Study 31343513 — intervention group
Group type: COMPARATOR
Intervention: Proclear 1-day (control)
Number of subjects: 144
Study 28489244 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine
Number of subjects: 22
Study 28489244 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 22
Study 26201187 — intervention group
Group type: EXPERIMENTAL
Intervention: Sublingual immunotherapy (SLIT)
Number of subjects: 112
Study 26201187 — intervention group
Group type: COMPARATOR
Intervention: Control (medical treatment)
Number of subjects: 112
Study 24180582 — intervention group
Group type: EXPERIMENTAL
Intervention: Clindamycin
Number of subjects: 30
Study 24180582 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (placebo)
Number of subjects: 30
Study 22140666 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronally advanced flap surgery combined with CO2 laser root conditioning (CAF + CO2)
Number of subjects: 25
Study 22140666 — intervention group
Group type: COMPARATOR
Intervention: Modified Widman flap surgery (MW)
Number of subjects: 25
Study 19508900 — intervention group
Group type: EXPERIMENTAL
Intervention: Celecoxib (specific dosage and duration not mentioned)
Number of subjects: 137
Study 19508900 — intervention group
Group type: EXPERIMENTAL
Intervention: Radio advertisements
Number of subjects: 137
Study 19508900 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet postings
Number of subjects: 137
Study 19508900 — intervention group
Group type: EXPERIMENTAL
Intervention: Print media
Number of subjects: 137
Study 19508900 — intervention group
Group type: EXPERIMENTAL
Intervention: Posted and racked flyers
Number of subjects: 137
Study 19508900 — intervention group
Group type: EXPERIMENTAL
Intervention: Mass mailings
Number of subjects: 137
Study 19508900 — intervention group
Group type: EXPERIMENTAL
Intervention: Other strategies (referrals)
Number of subjects: 137
Study 17348993 — intervention group
Group type: EXPERIMENTAL
Intervention: Avène thermal spring water (ATSW)
Number of subjects: 25
Study 17348993 — intervention group
Group type: COMPARATOR
Intervention: Comparative water spray
Number of subjects: 25
Study 15586841 — intervention group
Group type: EXPERIMENTAL
Intervention: Feeling Thermometer with marker states (FT+)
Number of subjects: 217
Study 15586841 — intervention group
Group type: COMPARATOR
Intervention: Feeling Thermometer without marker states (FT-)
Number of subjects: 217
Study 15586841 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Gamble with marker states (SG+)
Number of subjects: 217
Study 15586841 — intervention group
Group type: COMPARATOR
Intervention: Standard Gamble without marker states (SG-)
Number of subjects: 217
Study 11505514 — intervention group
Group type: EXPERIMENTAL
Intervention: Fixed insole (lateral wedged insole with elastic fixation of the subtalar joint)
Number of subjects: 71
Study 11505514 — intervention group
Group type: COMPARATOR
Intervention: Inserted insole (traditional shoe insert wedged insoles)
Number of subjects: 71
Study 9543954 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational video and peer counseling intervention
Number of subjects: 242
Study 7843473 — intervention group
Group type: EXPERIMENTAL
Intervention: Bespoke shoes (cushioned shoes prescribed up to 2 pairs on request)
Number of subjects: 85
Study 7843473 — intervention group
Group type: COMPARATOR
Intervention: Normal shoes (control group)
Number of subjects: 85
Study 7843473 — intervention group
Group type: EXPERIMENTAL
Intervention: Bespoke shoes (cases)
Number of subjects: 85
Study 7843473 — intervention group
Group type: COMPARATOR
Intervention: Normal shoes (controls)
Number of subjects: 85
Study 2450441 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium 0.1 mg kg‐1
Number of subjects: 60
Study 2450441 — intervention group
Group type: COMPARATOR
Intervention: Pancuronium 0.6 mg kg‐1
Number of subjects: 60
Study 29694816 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral azithromycin (approximately 20 mg per kilogram of body weight)
Number of subjects: 190238
Study 29694816 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 190238
Study 29694816 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral azithromycin
Number of subjects: 190238
Study 29326491 — intervention group
Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 144
Study 29326491 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl-midazolam
Number of subjects: 144
Study 29326491 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 144
Study 25179766 — intervention group
Group type: EXPERIMENTAL
Intervention: Home Monitoring facilitated follow-up (HM ON)
Number of subjects: 312
Study 25179766 — intervention group
Group type: COMPARATOR
Intervention: Regular in-office follow-up (HM OFF)
Number of subjects: 312
Study 23299396 — intervention group
Group type: COMPARATOR
Intervention: Response Signals (RS)
Number of subjects: 0
Study 23299396 — intervention group
Group type: EXPERIMENTAL
Intervention: Deadlines (DL)
Number of subjects: 0
Study 23299396 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance-contingent payment (Experiment 3)
Number of subjects: 0
Study 23299396 — intervention group
Group type: EXPERIMENTAL
Intervention: Flat payment (Experiment 2)
Number of subjects: 0
Study 20686919 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser pulse length of 0.604mS (group I)
Number of subjects: 240
Study 20686919 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser pulse length of 0.708mS (group II)
Number of subjects: 240
Study 20686919 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser pulse length of 1.010mS (group III)
Number of subjects: 240